ANI Pharmaceuticals | ANIP - Operating Profit

Stock Price
78.01
Daily Change
-1.57 -1.97%
Monthly
-0.08%
Yearly
30.04%
Q2 Forecast
76.44

ANI Pharmaceuticals reported $38.71M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
ANI Pharmaceuticals USD 38.71M 9.58M Mar/2026
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Emergent BioSolutions USD -218M 69.9M Jun/2023
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novartis USD 4.06B 521M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Perrigo USD 33.6M 50.8M Mar/2026
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
Teva Pharmaceutical Industries USD 758M 271M Mar/2026